DCM
EPIX

Driehaus Capital Management’s ESSA Pharma EPIX Stock Holding History

Driehaus Capital Management’s Portfolio EPIX Stock Details EPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-28,300
Closed -$76.4K – 401
2023
Q2 		$76.4K Sell
28,300
-236,271
-89% -$693K ﹤0.01% 380
2023
Q1 		$786K Hold
264,571
– – 0.01% 333
2022
Q4 		$667K Buy
+264,571
New +$759K 0.01% 309
2021
Q3 		– Sell
-348,524
Closed -$9.96M – 419
2021
Q2 		$9.96M Sell
348,524
-202,598
-37% -$5.89M 0.13% 224
2021
Q1 		$16M Sell
551,122
-497,402
-47% -$11.6M 0.24% 133
2020
Q4 		$12.5M Buy
1,048,524
+668,524
+176% +$4.71M 0.2% 152
2020
Q3 		$2.62M Buy
+380,000
New +$2.58M 0.05% 247

Other funds holding EPIX

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $1.06B AUM 52.03% 1-Year Est. Return

Driehaus Capital Management's EPIX Position: Q3 2023 in Review

Driehaus Capital Management sold out of ESSA Pharma (EPIX) in Q3 2023, closing a stake of 28,300 shares — an estimated $76.4K sold.

Driehaus Capital Management first reported a position in EPIX in Q3 2020 and held it in 7 quarters. The position peaked at $16M in Q1 2021. 36 funds tracked by Wall St. Rank hold EPIX as of Q3 2023.

  • Driehaus Capital Management reported no remaining ESSA Pharma position as of Q3 2023 after selling out during the quarter.
  • Driehaus Capital Management sold 28,300 ESSA Pharma shares in Q3 2023, an estimated $76.4K.
  • Driehaus Capital Management first reported a position in ESSA Pharma in Q3 2020 and held it in 7 quarters.
  • Driehaus Capital Management's ESSA Pharma position peaked at $16M in Q1 2021.
  • 36 funds tracked by Wall St. Rank held ESSA Pharma as of Q3 2023.

Based on Driehaus Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.